SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-04-000229
Filing Date
2004-02-17
Accepted
2004-02-17 10:35:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g-guilfordpharma12312003.txt SC 13G 53709
  Complete submission text file 0000913414-04-000229.txt   55820
Mailing Address 45 FREMONT ST SAN FRANCISCO CA 94105
Business Address 45 FREMONT ST 17TH FL SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

IRS No.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45277 | Film No.: 04604563
SIC: 2834 Pharmaceutical Preparations